Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging of ZULRESSO in Postpartum Depression
NCT04273191Phase 4Withdrawn
- Sponsor
- Sage Therapeutics
- Start
- Feb 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of brexanolone in postpartum depression (PPD), sponsored by Sage Therapeutics. Planned start Feb 2020; status: withdrawn.
02
Drugs
brexanolone
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT04273191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273191.